Clik here to view.
NASA scientists take on muscular atrophy with drug-loaded implant
Scientists aboard the International Space Station plan to study if a drug-eluting implant can prevent, slow or even turn back the muscular breakdown observed in astronauts when they fly for an extended...
View ArticleClik here to view.
Ocular Therapeutix closes $35m offering
Ocular Therapeutix (NSDQ:OCUL) has closed an underwritten public offering of 7,475,000 shares of its common stock at $5.00 apiece, reeling in $35.1 million to fund the planned resubmission of its new...
View ArticleClik here to view.
Medtronic’s In.Pact Admiral drug-coated balloon succeeds in two-year study,...
Medtronic (NYSE:MDT) touted data today from a two-year study of its In.Pact Admiral drug-coated balloon in patients with peripheral artery disease in Japan, as well as the results from a critical limb...
View ArticleClik here to view.
Sunovion touts pivotal Ph3 trial for Parkinson’s drug
Gearing up for a springtime FDA submission, Sunovion Pharmaceuticals reported today that its apomorphine sublingual film succeeded in a pivotal Phase III trial in patients with Parkinson’s disease who...
View ArticleClik here to view.
BioCardia wins FDA nod for chronic myocardial ischemia pivotal trial
The FDA has approved a trial to test BioCardia‘s (OTC:BCDA) CardiAMP cell therapy in chronic myocardial ischemia patients with refractory angina. The San Carlos, Calif.-based company could enroll up to...
View ArticleClik here to view.
Ensysce Bioscience wins fast track status for abuse-deterrent oxycodone
Ensysce Biosciences said this week that its extended-release oxycodone prodrug won fast track status from the FDA. The San Diego, Calif.-based company is developing the abuse-deterrent drug as a pain...
View ArticleClik here to view.
Verily, Sanofi and other industry players team up with NIH to advance...
The National Institutes of Health is joining forces with the tech and pharmaceutical industries to speed the development of new drugs for Parkinson’s disease and identify biomarkers for the...
View ArticleClik here to view.
Boston Scientific’s drug-coated balloon goes up against Medtronic’s DCB in...
Top-line results from a head-to-head trial comparing Boston Scientific‘s (NYSE:BSX) Ranger drug-coated balloon and Medtronic‘s (NYSE:MDT) In.Pact Admiral DCB found no statistically significant...
View ArticleClik here to view.
Eli Lilly beats the Street with Q4 earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly this morning even though the pharmaceutical company beat analysts’ estimates with its fourth quarter and full-year financial results. The Indianapolis-based...
View ArticleClik here to view.
Arkray inks licensing deal with Mellitus Health for insulin titration software
Arkray‘s U.S. business has inked a licensing deal with Mellitus Healthfor its insulin titration software, Insulin Insights. Mellitus Health, formerly known as Insulin Algorithms, developed the clinical...
View ArticleClik here to view.
Teva closes $703m sale of global women’s health biz to CVC Capital
Teva Pharmaceuticals (NYSE:TEVA) has finished the $703 million sale of a portfolio of products in its global women’s health business to CVC Capital Partners. The portfolio of divested products includes...
View ArticleClik here to view.
Baxter posts Street-beating Q4 earnings, sales
Shares in Baxter (NYSE:BAX) fell slightly this morning after the company topped expectations on Wall Street with its fourth quarter and full-year results. The Deerfield, Ill.-based company swung to a...
View ArticleClik here to view.
Shares in Novo Nordisk sink after Q4 earnings, sales disappoint
Shares in Novo Nordisk (NYSE:NVO) fell today after the insulin-maker missed expectations on Wall Street with its fourth quarter and full-year financial results. The Denmark-based company posted profits...
View ArticleClik here to view.
Novocure touts quality-of-life analysis for glioblastoma patients treated...
Novocure (NSDQ:NVCR) today touted an analysis published in JAMA Oncology showing that its Optune-temozolomide combination helped newly-diagnosed glioblastoma patients live longer without hurting their...
View ArticleClik here to view.
Court dismisses class action suit against InfuSystem
The U.S. District Court for the Central District of California has dismissed a class action lawsuit against InfuSystem (NYSE:INFU) alleging that the company, its ex-CEO and former chief finance...
View ArticleClik here to view.
OncoSec Medical prices $20m public offering
OncoSec Medical (NSDQ:ONCS) today priced an underwritten public offering of 13,333,334 shares of its common stock at $1.50 apiece. The San Diego, Calif.-based company expects the offering to bring in...
View ArticleClik here to view.
Anika collabs to develop injectable stem cell therapy for osteoarthritis
Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat...
View ArticleClik here to view.
The flu season is making a shortage of IV fluids worse – here’s what the FDA...
This year’s flu season has been exceptionally bad – it’s already claimed the lives of dozens of kids and it’s more widespread than any other year on record, according to the Centers for Disease Control...
View ArticleClik here to view.
Cardinal Health closes $1B China biz sale
Cardinal Health (NYSE:CAH) said today it closed its $1.2 billion sale of its Cardinal Health China business to Shanghai Pharmaceuticals. The deal covers Dublin, Ohio-based Cardinal’s pharmaceutical...
View ArticleClik here to view.
Amgen swings to a loss in Q4 after $6B hit from tax reform
Shares in Amgen (NSDQ:AMGN) rose slightly today after the biotech missed expectations on Wall Street with its fourth-quarter earnings, but topped EPS estimates for the year ahead. The Thousand Oaks,...
View Article